Biomedical Engineering Reference
In-Depth Information
134. Huikeshoven M, Koster PH, de Borgie CA, et al. Redarkening of port-
wine stains 10 years after pulsed-dye-laser treatment. N Engl J Med
2007; 356: 1235-40.
135. Esterly NB. Cutaneous hemangiomas, vascular stains and malforma-
tions, and associated syndromes. Curr Probl Pediatr 1996; 26: 3-39.
136. Burton BK, Schulz CJ, Angle B, Burd LI. An increased incidence of hae-
mangiomas in infants born following chorionic villus sampling (CVS).
Prenat Diagn 1995; 15: 209-14.
137. Amir J, Metzker A, Krikler R, Reisner SH. Strawberry hemangioma in
preterm infants. Pediatr Dermatol 1986; 3: 331-2.
138. North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discov-
ered immunohistochemical marker for juvenile hemangiomas. Hum
Pathol 2000; 31: 11-22.
139. Boscolo E, Bischoff J. Vasculogenesis in infantile hemangioma. Angio-
genesis 2009; 12: 197-207.
140. Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of
infantile hemangiomas: implications for management. Pediatrics 2008;
122: 360-7.
141. Bivings L. Spontaneous regression of angiomas in children; twenty-two
years' observation covering 236 cases. J Pediatr 1954; 45: 643-7.
142. Garzon MC, Frieden IJ. Hemangiomas: when to worry. Pediatr Ann
2000; 29: 58-67.
143. Garzon M. Hemangiomas: update on classifi cation, clinical presenta-
tion, and associated anomalies. Cutis 2000; 66: 325-8.
144. Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical
characteristics, morphologic subtypes, and their relationship to race,
ethnicity, and sex. Arch Dermatol 2002; 138: 1567-76.
145. Haggstrom AN, Lammer EJ, Schneider RA, Marcucio R, Frieden IJ. Pat-
terns of infantile hemangiomas: new clues to hemangioma pathogenesis
and embryonic facial development. Pediatrics 2006; 117: 698-703.
146. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile
hemangiomas: demographic, prenatal, and perinatal characteristics.
J Pediatr 2007; 150: 291-4.
147. Tanner JL, Dechert MP, Frieden IJ. Growing up with a facial hemangi-
oma: parent and child coping and adaptation. Pediatrics 1998; 101:
446-52.
148. Frieden IJ, Reese V, Cohen D. PHACE syndrome. The association of pos-
terior fossa brain malformations, hemangiomas, arterial anomalies,
coarctation of the aorta and cardiac defects, and eye abnormalities. Arch
Dermatol 1996; 132: 307-11.
149. Ceisler EJ, Santos L, Blei F. Periocular hemangiomas: what every physi-
cian should know. Pediatr Dermatol 2004; 21: 1-9.
150. Goldberg NS, Hebert AA, Esterly NB. Sacral hemangiomas and multiple
congenital abnormalities. Arch Dermatol 1986; 122: 684-7.
151. Geller JD, Topper SF, Hashimoto K. Diffuse neonatal hemangiomatosis:
a new constellation of fi ndings. J Am Acad Dermatol 1991; 24: 816-18.
152. Holden KR, Alexander F. Diffuse neonatal hemangiomatosis. Pediatrics
1970; 46: 411-21.
153. Enjolras O, Wassef M, Mazoyer E, et al. Infants with Kasabach-Merritt
syndrome do not have “true” hemangiomas. J Pediatr 1997; 130: 631-40.
154. Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: cur-
rent knowledge, future directions. Proceedings of a research workshop
on infantile hemangiomas; Bethesda, Maryland, USA, April 7-9, 2005.
Pediatr Dermatol 2005. 22(5):383-406.
155. Kim HJ, Colombo M, Frieden IJ. Ulcerated hemangiomas: clinical charac-
teristics and response to therapy. J Am Acad Dermatol 2001; 44: 962-72.
156. Morelli JG, Tan OT, Weston WL. Treatment of ulcerated hemangiomas
with the pulsed tunable dye laser. Am J Dis Child 1991; 145: 1062-4.
157. David LR, Malek MM, Argenta LC. Effi cacy of pulse dye laser therapy for
the treatment of ulcerated haemangiomas: a review of 78 patients. Br J
Plast Surg 2003; 56: 317-27.
158. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-
threatening hemangiomas of infancy. N Engl J Med 1992; 326: 1456-63.
159. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complica-
tion of interferon Alfa-2a treatment of hemangiomas of infancy. J Pedi-
atr 1998; 132: 527-30.
160. Jiang C, Hu X, Ma G, et al. A prospective self-controlled phase II study of
imiquimod 5% cream in the treatment of infantile hemangioma. Pediatr
Dermatol 2011; 28: 259-66.
161. Bassukas ID, Abuzahra F, Hundeiker M. Regression phase as therapeutic
goal of cryosurgical treatment of growing capillary infantile hemangio-
mas. Treatment decision, treatment strategy and results of an open clin-
ical study. Hautarzt 2000; 51: 231-8.
162. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol
for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-51.
163. Jinnin M, Medici D, Park L, et al. Suppressed NFAT-dependent VEGFR1
expression and constitutive VEGFR2 signaling in infantile hemangioma.
Nat Med 2008; 14: 1236-46.
164. Pope E, Chakkittakandiyil A. Topical timolol gel for infantile hemangio-
mas: a pilot study. Arch Dermatol 2010; 146: 564-5.
165. Garden JM, Bakus AD, Paller AS. Treatment of cutaneous hemangiomas
by the fl ashlamp-pumped pulsed dye laser: prospective analysis. J Pedi-
atr 1992; 120: 555-60.
166. Barlow RJ, Walker NP, Markey AC. Treatment of proliferative hae-
mangiomas with the 585 nm pulsed dye laser. Br J Dermatol 1996; 134:
700-4.
167. Hohenleutner U, Landthaler M. Laser treatment of childhood haeman-
gioma: progress or not? Lancet 2002; 360: 502-3.
168. Batta K, Goodyear HM, Moss C, et al. Randomised controlled study of
early pulsed dye laser treatment of uncomplicated childhood haeman-
giomas: results of a 1-year analysis. Lancet 2002; 360: 521-7.
169. Batta K, Goodyear HM, Moss C, et al. Randomised controlled study of
early pulsed dye laser treatment of uncomplicated childhood haeman-
giomas: results of a 1-year analysis. Lancet 2002; 360: 521-7.
170. Leonardi-Bee J, Batta K, O'Brien C, Bath-Hextall FJ. Interventions for
infantile haemangiomas (strawberry birthmarks) of the skin. Cochrane
Database Syst Rev: CD006545.
171. Raulin C, Greve B. Retrospective clinical comparison of hemangioma
treatment by fl ashlamp-pumped (585 nm) and frequency-doubled
Nd:YAG (532 nm) lasers.[erratum appears in Lasers Surg Med
2001;29(3):293]. Lasers Surg Med 2001; 28: 40-3.
172. Berlien HP, Muller G, Waldschmidt J. Lasers in pediatric surgery. Prog
Pediatr Surg 1990; 25: 5-22.
173. Alcantara Gonzalez J, Boixeda P, Truchuelo Diez MT, Lopez
Gutierrez JC, Olasolo PJ. Ablative fractional yttrium-scandium-gallium-
garnet laser for scarring residual haemangiomas and scars secondary
to their surgical treatment. J Eur Acad Dermatol Venereol 2012; 26:
477-82.
174. Antony FC, Cliff S, Cowley N. Complete pain relief following treatment
of a glomangiomyoma with the pulsed dye laser. Clin Exp Dermatol
2003; 28: 617-19.
175. Hughes R, Lacour JP, Chiaverini C, Rogopoulos A, Passeron T. Nd:YAG
laser treatment for multiple cutaneous glomangiomas: report of 3 cases.
Arch Dermatol 2011; 147: 255-6.
176. Weiss ET, Geronemus RG. New technique using combined pulsed dye
laser and fractional resurfacing for treating facial angiofi bromas in
tuberous sclerosis. Lasers Surg Med 2010; 42: 357-60.
177. Karen JK, Hale EK, Geronemus RG. A simple solution to the common
problem of ecchymosis. Arch Dermatol 2010; 146: 94-5.
178. Karsai S, Roos S, Hammes S, Raulin C. Pulsed dye laser: what's new in
non-vascular lesions? J Eur Acad Dermatol Venereol 2007; 21: 877-90.
179. Hern S, Allen MH, Sousa AR, et al. Immunohistochemical evaluation of
psoriatic plaques following selective photothermolysis of the superfi cial
capillaries. Br J Dermatol 2001; 145: 45-53.
180. Binder B, Weger W, Komericki P, Kopera D. Treatment of molluscum
contagiosum with a pulsed dye laser: Pilot study with 19 children.
J Dtsch Dermatol Ges 2008; 6: 121-5.
181. Segura Palacios JM, Boixeda P, Rocha J, et al. Laser treatment for verru-
cous hemangioma. Lasers Med Sci 2012; 27: 681-4.
182. Sethuraman G, Richards KA, Hiremagalore RN, Wagner A. Effectiveness
of pulsed dye laser in the treatment of recalcitrant warts in children.
Dermatol Surg 2010; 36: 58-65.
183. Schellhaas U, Gerber W, Hammes S, Ockenfels HM. Pulsed dye laser
treatment is effective in the treatment of recalcitrant viral warts. Derma-
tol Surg 2008; 34: 67-72.
184. Park HS, Kim JW, Jang SJ, Choi JC. Pulsed dye laser therapy for pediatric
warts. Pediatr Dermatol 2007; 24: 177-81.
185. Borovoy MA, Borovoy M, Elson LM, Sage M. Flashlamp pulsed dye laser
(585 nm). Treatment of resistant verrucae. J Am Podiatr Med Assoc
1996; 86: 547-50.
186. Webster GF, Satur N, Goldman MP, Halmi B, Greenbaum S. Treatment
of recalcitrant warts using the pulsed dye laser. Cutis 1995; 56: 230-2.
